Tech Center 1600 • Art Units: 1622 1624
This examiner grants 82% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19426142 | PRMT5 INHIBITORS AND METHODS OF USE | Non-Final OA | SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED |
| 18543130 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND TITANIUM DIOXIDE | Non-Final OA | L'OREAL |
| 18562100 | TREATMENT OF INFECTIONS IN AND AROUND THE EYE | Non-Final OA | UNIVERSITY OF MIAMI |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy